Nai Kong V Cheung (Nai-Kong V Cheung, Nai-Kong Cheung, Nai K Cheung, Nai Kong Cheung)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 47

Top Topics

Acute Myeloid Leukemia

Monoclonal Antibody

Top Venues

Journal for immunotherapy of cancer

bioRxiv : the preprint server for biology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbra Rosati, David Carlson, Nai Kong V Cheung, Hong Xu, James Bean, Katherine Hsu, Jean-Benoit Le Luduec, Charles Kyriakos Vorkas
Loss of circulating CD8α + NK cells during human Mycobacterium tuberculosis infection. bioRxiv : the preprint server for biology (2024)
Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbra Rosati, David Carlson, Nai Kong V Cheung, Hong Xu, James Bean, Katherine Hsu, Jean-Benoit Le Luduec, Charles Kyriakos Vorkas
Loss of circulating CD8α + NK cells during human Mycobacterium tuberculosis infection. bioRxiv : the preprint server for biology (2024)
Jeong A Park, Nai Kong V Cheung
Immunotherapies for Childhood Cancer. Cold Spring Harbor perspectives in medicine (2024)
Irene Y Cheung, Audrey Mauguen, Shakeel Modak, Ellen M Basu, Yi Feng, Brian H Kushner, Nai Kong V Cheung
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine. Vaccines 12 (6) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Irene Y Cheung, Audrey Mauguen, Shakeel Modak, Ellen M Basu, Yi Feng, Brian H Kushner, Nai Kong V Cheung
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine. Vaccines 12 (6) (2024)
Natasha V Persaud, Jeong A Park, Nai Kong V Cheung
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy. Journal of clinical medicine 13 (16) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbara Rosati, David Carlson, Nai Kong V Cheung, Hong Xu, James Bean, Katherine Hsu, Jean-Benoit Le Luduec, Charles Kyriakos Vorkas
Loss of circulating CD8α + NK cells during human Mycobacterium tuberculosis infection. bioRxiv : the preprint server for biology (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Natasha V Persaud, Jeong A Park, Nai Kong V Cheung
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy. Journal of clinical medicine 13 (16) (2024)
Natasha V Persaud, Jeong A Park, Nai Kong V Cheung
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy. Journal of clinical medicine 13 (16) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Irene Y Cheung, Audrey Mauguen, Shakeel Modak, Ellen M Basu, Yi Feng, Brian H Kushner, Nai Kong V Cheung
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine. Vaccines 12 (6) (2024)
Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbara Rosati, David Carlson, Nai Kong V Cheung, Hong Xu, James Bean, Katherine Hsu, Jean-Benoit Le Luduec, Charles Kyriakos Vorkas
Loss of circulating CD8α + NK cells during human Mycobacterium tuberculosis infection. bioRxiv : the preprint server for biology (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Jeong A Park, Nai Kong V Cheung
Immunotherapies for Childhood Cancer. Cold Spring Harbor perspectives in medicine (2024)
Madelyn Espinosa-Cotton, Sayed Shahabuddin Hoseini, Ileana C Miranda, John Herrick, Nai Kong V Cheung
Targeting T cells with tetravalent bispecific antibodies for the treatment of graft versus host disease. Blood advances (2024)
Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbara Rosati, David Carlson, Nai Kong V Cheung, Hong Xu, James Bean, Katherine Hsu, Jean-Benoit Le Luduec, Charles Kyriakos Vorkas
Loss of circulating CD8α + NK cells during human Mycobacterium tuberculosis infection. bioRxiv : the preprint server for biology (2024)
Cristina Larrosa, Jaume Mora, Nai Kong V Cheung
Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2. Cancers 15 (14) (2023)
Jeong A Park, Nai Kong V Cheung
Promise and Challenges of T Cell Immunotherapy for Osteosarcoma. International journal of molecular sciences 24 (15) (2023)
Jeong A Park, Madelyn Espinosa-Cotton, Hong-Fen Guo, Sebastien Monette, Nai Kong V Cheung
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. Journal for immunotherapy of cancer 11 (3) (2023)
Gunes Gundem, Max F Levine, Stephen S Roberts, Irene Y Cheung, Juan S Medina-Martínez, Yi Feng, Juan Esteban Arango Ossa, Loic Chadoutaud, Mathieu Rita, Georgios Asimomitis, Joe Zhou, Daoqi You, Nancy Bouvier, Barbara Spitzer, David B Solit, Filemon Dela Cruz, Michael P LaQuaglia, Brian H Kushner, Shakeel Modak, Neerav Shukla, Christine A Iacobuzio-Donahue, Andrew L Kung, Nai Kong V Cheung, Elli Papaemmanuil
Clonal evolution during metastatic spread in high-risk neuroblastoma. Nature genetics (2023)
Barbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, Erin M McGovern, Nathan E Millard, Juan E Arango Ossa, Irene Y Cheung, Teng Gao, Max F Levine, Yanming Zhang, Juan Santiago Medina-Martinez, Yi Feng, Ryan N Ptashkin, Kelly L Bolton, Noushin Farnoud, Yangyu Zhou, Minal A Patel, Georgios Asimomitis, Cassidy C Cobbs, Neeman Mohibullah, Kety H Huberman, Maria E Arcilla, Brian H Kushner, Shakeel Modak, Andrew L Kung, Ahmet Zehir, Ross L Levine, Scott A Armstrong, Nai Kong V Cheung, Elli Papaemmanuil
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Tsung-Yi Lin, Jeong A Park, Alan Long, Hong-Fen Guo, Nai Kong V Cheung
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy. Journal for immunotherapy of cancer 9 (9) (2022)
Jeong A Park, Nai Kong V Cheung
Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies. Journal for immunotherapy of cancer 10 (1) (2022)
Jeong A Park, Brian H Santich, Hong Xu, Lawrence G Lum, Nai Kong V Cheung
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release. Journal for immunotherapy of cancer 9 (5) (2022)
Sayed Shahabuddin Hoseini, Mallika Vadlamudi, Madelyn Espinosa-Cotton, Hoa Tran, Yi Feng, Hong-Fen Guo, Hong Xu, Irene Cheung, Nai Kong V Cheung
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. Journal for immunotherapy of cancer 9 (5) (2022)
Christopher S Chandler, Meghan M Bell, Sebastian K Chung, Darren R Veach, Edward K Fung, Blesida Punzalan, Daniela Burnes Vargas, Mitesh Patel, Hong Xu, Hong-Fen Guo, Brian H Santich, Pat B Zanzonico, Sebastien Monette, Garrett M Nash, Andrea Cercek, Achim Jungbluth, Neeta Pandit-Taskar, Nai Kong V Cheung, Steven M Larson, Sarah M Cheal
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis. Molecular cancer therapeutics (2021)
Carolyn A Felix, Diana J Slater, James W Davenport, Juan R Alvarez-Dominguez, Brian D Gregory, Marilyn M Li, Eric F Rappaport, Nai Kong V Cheung
KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up. Pediatric blood & cancer 69 (1) (2021)
Sai Kiran Sharma, Maya Suzuki, Hong Xu, Joshua A Korsen, Zachary Samuels, Hongfen Guo, Brandon Nemieboka, Alessandra Piersigilli, Kimberly J Edwards, Nai Kong V Cheung, Jason S Lewis
Influence of Fc modifications and IgG subclass on biodistribution of humanized antibodies targeting L1CAM. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Farhana Yesmin, Robiul H Bhuiyan, Yuhsuke Ohmi, Satoko Yamamoto, Kei Kaneko, Yuki Ohkawa, Pu Zhang, Kazunori Hamamura, Nai Kong V Cheung, Norihiro Kotani, Koichi Honke, Tetsuya Okajima, Mariko Kambe, Orie Tajima, Keiko Furukawa, Koichi Furukawa
Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins. International journal of molecular sciences 23 (1) (2021)
Jeong A Park, Linlin Wang, Nai Kong V Cheung
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response. Journal of hematology & oncology 14 (1) (2021)
Fiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, Kim Kramer, Brian H Kushner, Govind Ragupathi, Nai Kong V Cheung, Shakeel Modak
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma. Cancers 13 (24) (2021)
Megan M Dacek, Darren R Veach, Sarah M Cheal, Lukas M Carter, Michael R McDevitt, Blesida Punzalan, Daniela Burnes Vargas, Thomas Z Kubik, Sebastien Monette, Brian H Santich, Guangbin Yang, Ouathek Ouerfelli, Adam L Kesner, Nai Kong V Cheung, David A Scheinberg, Steven M Larson, Simone Krebs
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjugate chemistry 32 (4) (2021)
Hong Xu, Ilia N Buhtoiarov, Hongfen Guo, Nai Kong V Cheung
A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy. Oncoimmunology 10 (1) (2021)
Brian H Santich, Jeong A Park, Hoa Tran, Hong-Fen Guo, Morgan Huse, Nai Kong V Cheung
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Science translational medicine 12 (534) (2021)
Jeong A Park, Nai Kong V Cheung
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma. Journal of hematology & oncology 13 (1) (2020)
Brian H Santich, Sarah M Cheal, Mahiuddin Ahmed, Michael R McDevitt, Ouathek Ouerfelli, Guangbin Yang, Darren R Veach, Edward K Fung, Mitesh Patel, Daniela Burnes Vargas, Aiza A Malik, Hong-Fen Guo, Pat B Zanzonico, Sebastien Monette, Adam O Michel, Charles M Rudin, Steven M Larson, Nai Kong V Cheung
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Shakeel Modak, Pat Zanzonico, Milan Grkovski, Emily K Slotkin, Jorge A Carrasquillo, Serge K Lyashchenko, Jason S Lewis, Irene Y Cheung, Todd E Heaton, Michael P LaQuaglia, Nai Kong V Cheung, Neeta Pandit-Taskar
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Dana L Casey, Nai Kong V Cheung
Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies. Cancer immunology research 8 (2) (2020)
Shun Li, Ming Liu, Mytrang H Do, Chun Chou, Efstathios G Stamatiades, Briana G Nixon, Wei Shi, Xian Zhang, Peng Li, Shengyu Gao, Kristelle J Capistrano, Hong Xu, Nai Kong V Cheung, Ming O Li
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells. Nature 587 (7832) (2020)
Samuel L Brady, Yanling Liu, Xiaotu Ma, Alexander M Gout, Kohei Hagiwara, Xin Zhou, Jian Wang, Michael Macias, Xiaolong Chen, John Easton, Heather L Mulder, Michael C Rusch, Lu Wang, Joy Nakitandwe, Shaohua Lei, Eric M Davis, Arlene Naranjo, Cheng Cheng, John M Maris, James R Downing, Nai Kong V Cheung, Michael D Hogarty, Michael A Dyer, Jinghui Zhang
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. Nature communications 11 (1) (2020)
Sayed Shahabuddin Hoseini, Hongfen Guo, Zhihao Wu, Miho Nakajima Hatano, Nai Kong V Cheung
A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood advances 2 (11) (2019)
Linlin Wang, Sayed Shahabuddin Hoseini, Hong Xu, Vladimir Ponomarev, Nai Kong V Cheung
Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer immunology research 7 (12) (2019)
Shakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, Debra A Goldman, Irina Ostrovnaya, Ekaterina Doubrovina, Ellen Basu, Brian H Kushner, Kim Kramer, Stephen S Roberts, Richard J O'Reilly, Nai Kong V Cheung, Katharine C Hsu
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study. Oncoimmunology 7 (8) (2018)